Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections

Изучение гликолитических ферментов при заболеваниях: потенциальные биомаркеры и терапевтические мишени при нейродегенеративных заболеваниях, раке и паразитарных инфекциях
Wilfredo A. Quiñones, Paul A.M. Michels, Juan Luís Concepción, Miguel Marcos, Maura Rojas-Pirela, Diego Andrade-Alviárez, Verónica Rojas, Daniel Salete-Granado, Marirene Chacón-Arnaude, María Á. Pérez-Nieto, Ulrike Kemmerling
2025-02-01

cancerglycolytic enzymesneurodegenerationparasitic infectionstherapeutic targets
Glycolysis, present in most organisms, is evolutionarily one of the oldest metabolic pathways. It has great relevance at a physiological level because it is responsible for generating ATP in the cell through the conversion of glucose into pyruvate and reducing nicotinamide adenine dinucleotide (NADH) (that may be fed into the electron chain in the mitochondria to produce additional ATP by oxidative phosphorylation), as well as for producing intermediates that can serve as substrates for other metabolic processes. Glycolysis takes place through 10 consecutive chemical reactions, each of which is catalysed by a specific enzyme. Although energy transduction by glucose metabolism is the main function of this pathway, involvement in virulence, growth, pathogen-host interactions, immunomodulation and adaptation to environmental conditions are other functions attributed to this metabolic pathway. In humans, where glycolysis occurs mainly in the cytosol, the mislocalization of some glycolytic enzymes in various other subcellular locations, as well as alterations in their expression and regulation, has been associated with the development and progression of various diseases. In this review, we describe the role of glycolytic enzymes in the pathogenesis of diseases of clinical interest. In addition, the potential role of these enzymes as targets for drug development and their potential for use as diagnostic and prognostic markers of some pathologies are also discussed.
1
Altered expression, regulation, or subcellular mislocalization of human glycolytic enzymes is associated with disease development and progression.
2
Beyond energy metabolism, glycolytic pathways contribute to virulence, pathogen–host interactions, immunomodulation, growth, and environmental adaptation.
3
Glycolysis supports ATP and NADH production while supplying metabolic intermediates for additional cellular processes.
4
Glycolytic enzymes are highlighted as potential therapeutic targets for drug development in neurodegeneration, cancer, and parasitic infections.
5
Glycolytic enzymes may serve as diagnostic and prognostic biomarkers for clinically relevant diseases.

Glycolytic enzymes in human diseases and parasitic infections, particularly neurodegeneration, cancer, and pathogen–host interactions

The roles, dysregulation, and disease-associated localization of glycolytic enzymes, including their potential as therapeutic targets and diagnostic or prognostic biomarkers

Publication Details
Publication Date
2025-02-01
Journal
Publisher
ISSN
Cited by
32
Access Type
Author Information
Authors
Wilfredo A. Quiñones
Paul A.M. Michels
Juan Luís Concepción
Miguel Marcos
Maura Rojas-Pirela
Diego Andrade-Alviárez
Verónica Rojas
Daniel Salete-Granado
Marirene Chacón-Arnaude
María Á. Pérez-Nieto
Ulrike Kemmerling
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%